These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21283255)

  • 1. In vivo characterization of fusion protein comprising of A1 subunit of Shiga toxin and human GM-CSF: Assessment of its immunogenicity and toxicity.
    Oloomi M; Bouzari S; Shariati E
    Iran Biomed J; 2010 Oct; 14(4):136-41. PubMed ID: 21283255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicology and pharmacokinetics of DT388-GM-CSF, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor (GM-CSF) in C57BL/6 mice.
    Hall PD; Kreitman RJ; Willingham MC; Frankel AE
    Toxicol Appl Pharmacol; 1998 May; 150(1):91-7. PubMed ID: 9630457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis on K562 cell line and double strand breaks on colon cancer cell line expressing high affinity receptor for granulocyte macrophage-colony stimulating factor (GM-CSF).
    Roudkenar MH; Bouzari S; Kuwahara Y; Roushandeh AM; Baba T; Oloomi M; Fukumoto M
    Iran Biomed J; 2008 Jan; 12(1):1-6. PubMed ID: 18392089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity.
    Dela Cruz JS; Trinh KR; Morrison SL; Penichet ML
    J Immunol; 2000 Nov; 165(9):5112-21. PubMed ID: 11046042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF.
    Zhai YZ; Li XM; Zhou Y; Ma L; Feng GH
    Intervirology; 2009; 52(3):152-63. PubMed ID: 19521104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant toxins containing human granulocyte-macrophage colony-stimulating factor and either pseudomonas exotoxin or diphtheria toxin kill gastrointestinal cancer and leukemia cells.
    Kreitman RJ; Pastan I
    Blood; 1997 Jul; 90(1):252-9. PubMed ID: 9207460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
    Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
    Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attempts to express the A1-GMCSF immunotoxin in the baculovirus expression vector system.
    Jahanian-Najafabadi A; Bouzari S; Oloomi M; Roudkenar MH; Mayr LM
    Biosci Biotechnol Biochem; 2012; 76(4):749-54. PubMed ID: 22484943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells.
    Chan CH; Blazar BR; Eide CR; Kreitman RJ; Vallera DA
    Blood; 1995 Oct; 86(7):2732-40. PubMed ID: 7670112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine.
    Weiss WR; Ishii KJ; Hedstrom RC; Sedegah M; Ichino M; Barnhart K; Klinman DM; Hoffman SL
    J Immunol; 1998 Sep; 161(5):2325-32. PubMed ID: 9725227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor.
    Kumar S; Villinger F; Oakley M; Aguiar JC; Jones TR; Hedstrom RC; Gowda K; Chute J; Stowers A; Kaslow DC; Thomas EK; Tine J; Klinman D; Hoffman SL; Weiss WW
    Immunol Lett; 2002 Apr; 81(1):13-24. PubMed ID: 11841841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
    Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
    J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model.
    Dou J; Wang Y; Wang J; Zhao F; Li Y; Cao M; Hu W; Hu K; He XF; Chu L; Jiang C; Gu N
    Immunobiology; 2009; 214(6):483-92. PubMed ID: 19389515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity.
    Tenbusch M; Kuate S; Tippler B; Gerlach N; Schimmer S; Dittmer U; Uberla K
    BMC Immunol; 2008 Apr; 9():13. PubMed ID: 18405363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J; Wu JH; Bouganim N; Galipeau J
    Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and characterization of a chimeric fusion protein consisting of an anti-idiotype antibody mimicking a breast cancer-associated antigen and the cytokine GM-CSF.
    Tripathi PK; Qin H; Bhattacharya-Chatterjee M; Ceriani RL; Foon KA; Chatterjee SK
    Hybridoma; 1999 Apr; 18(2):193-202. PubMed ID: 10380019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human immunodeficiency virus type 1 Env-granulocyte-macrophage colony-stimulating factor fusion protein enhances the cellular immune response to Env in a vaccinia virus-based vaccine.
    Rodr Guez D; Rodr Guez JR; Llorente M; V Zquez I; Lucas P; Esteban M; Mart Nez-A C; Del Real G
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():217-223. PubMed ID: 9934705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein.
    Frankel AE; Hall PD; Burbage C; Vesely J; Willingham M; Bhalla K; Kreitman RJ
    Blood; 1997 Nov; 90(9):3654-61. PubMed ID: 9345050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human ortholog of granulocyte macrophage colony-stimulating factor and interleukin-2 fusion protein induces potent ex vivo natural killer cell activation and maturation.
    Penafuerte C; Bautista-Lopez N; Boulassel MR; Routy JP; Galipeau J
    Cancer Res; 2009 Dec; 69(23):9020-8. PubMed ID: 19920194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.